Cite
HARVARD Citation
Waks, A. et al. (2022). Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer. Journal for immunotherapy of cancer. 10 (10), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Waks, A. et al. (2022). Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer. Journal for immunotherapy of cancer. 10 (10), p. . [Online].